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Abstract
BACKGROUND: A little evidence existed for ultrasound evaluation of coronavirus disease (COVID)-19 patients.
AIM: We aimed to present combined transthoracic echocardiography and lung ultrasound in 17 COVID-19 patients 
in the intensive care unit (ICU).
METHODS: Patients were on age 57 + 14 years, 9 on mechanical ventilation and 8 on oxygen support, with average 
1.2 comorbidities per patient. Ultrasound was performed by a single experienced sonographer and an assistant.
RESULTS: Impaired left ventricular ejection fraction (EF) was found in 2 patients (pts) of them (11.8%) and diastolic 
dysfunction in 7 (41.2%), which was significantly higher in those ones with comorbidities. In 2 pts (11.8%), the 
presence of pulmonary hypertension with enlarged right ventricle was found. Later one pulmonary thromboembolism 
was confirmed in them with computed tomography angio. B-lines were found in 8 pts (47.1%), finding that was 
significantly higher in pts on mechanical ventilation, but not in relation with decreased EF. In one pt (0.6%), pleural 
effusion was found, but in none of them lung consolidation.
CONCLUSIONS: Our findings revealed that combined echocardiography and lung ultrasound in COVID-19 ICU 
pts have been an accurate method for diagnosing right and left ventricular function and should be a useful one for 
guiding of their treatment and prognosis.
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Introduction
Nowadays, cardiopulmonary injury has been 
recognized in patients with coronavirus (CoV) disease 
(COVID)-19, the clinical disease state caused by infection 
with the novel CoV, severe acute respiratory syndrome 
(SARS)-CoV-2. While originally believed to be a primary 
lower respiratory infection, as more cases are identified, 
treated, and examined, thrombotic complications are being 
identified as a significant driver in morbidity and mortality 
associated with the disease. Elevated D-dimer levels and 
troponin values have been identified as being associated 
with increased mortality [1]. Yet, D-dimer and troponin 
could not prove a valuable tool to identify patients who are 
likely to have poorer outcomes and allow for prophylactic 
treatment and monitoring of secondary complications [2].
The first case that was confirmed in Republic 
of Macedonia by polymerase chain reaction (PCR) 
for SARS-CoV-2 virus in Institute for Public Health 
was on 26th of February 2020, and the first death was 
reported in Clinic of Infective Diseases on 25th of March 
same year. The case fatality rate for COVID-19 pts for 
Republic of Macedonia is 4.1.
Transthoracic echocardiography (TTE) is a 
basis for heart imaging, diagnosis of left and right ventricle 
overload, heart failure, but also for hemodynamic 
monitoring of these pts. European Association for 
Cardiovascular Imaging postulated consensus document 
for using a TTE in patients with COVID-19 [3].
However, a little evidence existed for 
echocardiographic evaluation of COVID-19 patients, 
combining it with a lung ultrasound in the intensive care 
unit (ICU) [4].
In this paper, we present a case series of 
17 patients COVID-19, evaluated with combined 
echocardiography and lung ultrasound.
Methods
The group consisted of COVID-19 patients 
(n = 17), hospitalized in the ICU of Clinic for Infective 
Disease in Skopje, with moderate and severe clinical 
symptoms. All tested positive for SARS-CoV-2 RNA 
through PCR in the Institute for Public Health.
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Ultrasound was performed by a single 
experienced physician and an assistant. Standard 
transthoracic echocardiographic evaluation was 
performed in all of pts. Bilateral lung ultrasound was 
done at all. GE Vivid T8 device was used.
Results
Patients were aged 57 + 14 years. Nine of 
them were on mechanical ventilation and 8 on oxygen 
support. Three of them died during hospitalization.
There were average 1.2 comorbidities per 
patient. Most frequent comorbidities were arterial 
hypertension (64.7%) and diabetes (58.9%). There 
were histories of cerebrovascular diseases in 1 pt, 
chronic pulmonary disease (chronic obstructive 
pulmonary disease and asthma) in 3 pts, and chronic 
kidney diseases in 2 pts. Malignant diseases, 
immunodeficiency disorders, were not noticed in the 
study population. At the admittance, most of the pts 
presented clinical symptoms of cough (9 pts), dyspnea 
(13 pts), and fever (7 pts).
In a study population mean value of D-dimmer 
(1300 ng/ml + 900), CRP (49 mg/L + 13), and white 
blood cell (19 × 109 + 5) was found. Antiviral therapy 
was administered in 13 pts and antibiotic in 15 of them.
Impaired left ventricular ejection fraction (EF) 
was found in 2 pts of them (11.8%), and diastolic 
dysfunction in 7 (41.2%), which was significantly higher 
in those ones with comorbidities (p < 0.05).
In 2 pts (11.8%), the presence of pulmonary 
hypertension with enlarged right ventricle was found 
(Figure 1). Later one pulmonary thromboembolism was 
confirmed in them with computed tomography (CT) 
angiography.
Figure 1: Increased diameter of the right ventricle
B-lines were found in 8 pts (47.1%), finding 
that was significantly higher in pts on mechanical 
ventilation, but not in relation with decreased EF. That 
was shown in Figure 2.
In one pt (0.6%), pleural effusion was found. 
In 9 pts (52.9%), irregular thickened pleural line was 
found (Figure 3). In none of them was found a lung 
consolidation.
Figure 3: Irregular thickened pleural line
Discussion
We found LV dysfunction in 11.8% of pts. It 
is not a very common condition in COVID-19 pts [5]. 
However, diastolic dysfunction is found in 42.3% of 
pts. Similar results were found in a study by Yishay 
Szekely [3]. Analysis of COVID-19 pts by Edler in 
International data found heart failure as a reason for 
death in one-third of them [6].
RV dysfunction is common findings in 
these pts. We found it in only 2 of pts. This is due 
to pulmonary thromboembolism (found in 11.8% of 
our pts), pneumonia, increase pulmonary vascular 
resistance [7]. Finding the reason for RV overloads 
sometimes in impossible if CT angio is not done. 
However is it very useful for administration for therapy.
Figure 2: B-lines in lung parenchyma
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Definition of pulmonary edema and interstitial 
lung disease is very controversial. One of the conditions 
that confirm interstitiopathy in the presence of B lines is 
normal LVEF. Distribution of B lines (no homogeneous) 
and fragmentation or irregularity of pleural line confirms 
lung disease. Lung ultrasound could potentially 
distinguish two types of disturbances. It has high 
sensitivity and low specificity to diagnose lung disease 
and pulmonary edema. It is more specific if the probe is 
used in lateral and posterior parts of the lungs. These 
could be increased by clinical settings of pts [8]. We 
found B lines in almost in half of the pts.
Focused echocardiography and lung 
ultrasound were also used for guiding treatment of pts 
with heart failure when administered serial [9].
There was a lack of ECG trace for echo 
images. X-ray was used in 3 pts and CT only in one 
pt. Non-randomization and non-homogeneity was also 
a study limitation.
This small case study group that we described 
allows identification and possible prognostication of 
CIVID-19 pts. Future larger studies are needed [10].
Conclusion
Our findings reveal that combined 
echocardiography and lung ultrasound in COVID-19 
ICU pts has been an accurate method for diagnosing 
right and left ventricular function and can be a useful 
one for guiding of their treatment and prognosis.
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